Anika Therapeutics, Inc. Deferred Tax Assets, Unrealized Currency Losses
Anika Therapeutics, Inc. (ANIK) had Deferred Tax Assets, Unrealized Currency Losses of $0 as of 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses · last filed 2026-03-03
- 2025-12-31: Deferred Tax Assets, Unrealized Currency Losses $0.00.
- 2024-12-31: Deferred Tax Assets, Unrealized Currency Losses $48.00K.
- 2023-12-31: Deferred Tax Assets, Unrealized Currency Losses $121.00K.
- 2022-12-31: Deferred Tax Assets, Unrealized Currency Losses $221.00K.
| Period end | Deferred Tax Assets, Unrealized Currency Losses |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-03 |
| 2024-12-31 | $48.00K 10-K · filed 2026-03-03 |
| 2023-12-31 | $121.00K 10-K · filed 2025-03-17 |
| 2022-12-31 | $221.00K 10-K · filed 2024-03-15 |
| 2021-12-31 | $282.00K 10-K · filed 2023-03-16 |
| 2020-12-31 | $229.00K 10-K · filed 2022-03-11 |
| 2019-12-31 | $346.00K 10-K/A · filed 2021-04-26 |
| 2018-12-31 | $363.00K 10-K · filed 2020-03-06 |
| 2017-12-31 | $265.00K 10-K · filed 2019-02-27 |
| 2016-12-31 | $677.00K 10-K · filed 2018-02-27 |
| 2015-12-31 | $762.00K 10-K · filed 2017-02-24 |
| 2014-12-31 | $353.00K 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |